The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials

Published:2019-05-28 Issue:6 Volume:70 Page:1913-1927
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Sanyal Arun J.¹,Harrison Stephen A.²,Ratziu Vlad³,Abdelmalek Manal F.⁴,Diehl Anna Mae⁴,Caldwell Stephen⁵,Shiffman Mitchell L.⁶,Aguilar Schall Raul⁷,Jia Catherine⁷,McColgan Bryan⁷,Djedjos C. Stephen⁷,McHutchison John G.⁷,Subramanian G. Mani⁷,Myers Robert P.⁷,Younossi Zobair⁸,Muir Andrew J.⁴,Afdhal Nezam H.⁹,Bosch Jaime¹⁰¹¹,Goodman Zachary⁸

Affiliation:

1. Virginia Commonwealth University Richmond VA

2. Pinnacle Clinical Research San Antonio TX

3. Hôpital Universitaire Pitié‐Salpêtrière Paris France

4. Duke Clinical Research Institute Durham NC

5. University of Virginia Charlottesville VA

6. Liver Institute of Virginia Richmond VA

7. Gilead Sciences, Inc Foster City CA

8. Inova Fairfax Hospital Falls ChurchVA

9. Beth Israel Deaconess Medical Center, Harvard Medical School Boston MA

10. Inselspital, Bern University Switzerland

11. IDIBAPS, University of Barcelona Barcelona Spain

Funder

Gilead Sciences

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.30664

Reference27 articles.

1. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

2. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

3. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe

4. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease

5. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data

Cited by 253 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Steatotic liver disease in the context of hematological malignancies and anti-neoplastic chemotherapy;Metabolism;2024-11

2. Natural history and progression of metabolic dysfunction-associated steatotic liver disease;The Lancet Gastroenterology & Hepatology;2024-10

3. Birth Weight, Gestational Age, and Risk of Pediatric-Onset MASLD;JAMA Network Open;2024-09-10

4. Digital quantitation of bridging fibrosis and septa reveals changes in natural history and treatment not seen with conventional histology;Liver International;2024-09-09

5. Hepatic immune regulation and sex disparities;Nature Reviews Gastroenterology & Hepatology;2024-09-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3